ConductScience.org, home

Trial · NCT00811590

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

NCT00811590, Phase 2, Terminated, University of Utah; results first posted 2012-07-04

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome. Trials, record NCT00811590. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00811590

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
NCT number
NCT00811590
Status
Terminated
Phases
Phase 2
Enrollment
3 participants, actual
Lead sponsor
University of Utah
Conditions
Peutz-Jeghers Syndrome
Interventions
Everolimus
First posted
2008-12-19
Last updated
2024-09-19
Results first posted
2012-07-04
Limitations and caveats
Early termination leading to small numbers of subjects analyzed

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe Size of Intestinal Polyps24 months

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYThe Size of Intestinal Polyps24 monthsDue to small enrollment number, analysis was not possible.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow3

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAll Patients3
Overall StudyCOMPLETEDAll Patients3
Overall StudyNOT COMPLETEDAll Patients0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals3

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityAll Patients
Total, other adverse eventsAll Patients03
Total, serious adverse eventsAll Patients03

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00811590

GET https://conductscience.org/api/trials/v1/NCT00811590/registered